Barclays Maintains Underweight on XPLR Infr, Raises Price Target to $9
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and raises the price target from $6 to $9.
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and raises the price target from $6 to $9.